| Literature DB >> 31413286 |
F Domenici1, A Capocefalo2, F Brasili3,2, A Bedini4, C Giliberti4, R Palomba4, I Silvestri5, S Scarpa6, S Morrone6, G Paradossi3, M D Frogley7, G Cinque7.
Abstract
Ultrasound (US) induced transient membrane permeabilisation has emerged as a hugely promising tool for the delivery of exogenous vectors through the cytoplasmic membrane, paving the way to the design of novel anticancer strategies by targeting functional <span class="Gene">nanomaterials to specific biological sites. An essential step towards this end is the detailed recognition of suitably marked nanoparticles in sonoporated cells and the investigation of the potential related biological effects. By taking advantage of Synchrotron Radiation Fourier Transform Infrared micro-spectroscopy (SR-microFTIR) in providing highly sensitive analysis at the single cell level, we studied the internalisation of a nanoprobe within fibroblasts (NIH-3T3) promoted by low-intensity US. To this aim we employed 20 nm gold nanoparticles conjugated with the IR marker 4-aminothiophenol. The significant Surface Enhanced Infrared Absorption provided by the nanoprobes, with an absorbance increase up to two orders of magnitude, allowed us to efficiently recognise their inclusion within cells. Notably, the selective and stable SR-microFTIR detection from single cells that have internalised the nanoprobe exhibited clear changes in both shape and intensity of the spectral profile, highlighting the occurrence of biological effects. Flow cytometry, immunofluorescence and murine cytokinesis-block micronucleus assays confirmed the presence of slight but significant cytotoxic and genotoxic events associated with the US-nanoprobe combined treatments. Our results can provide novel hints towards US and nanomedicine combined strategies for cell spectral imaging as well as drug delivery-based therapies.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31413286 PMCID: PMC6694135 DOI: 10.1038/s41598-019-48292-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Scheme of the protocols employed for the SR-microFTIR analyses. (A) the nanoprobe assembling was obtained by functionalising the AuNPs with the IR marker 4ATP; spectra were acquired after depositing the nanoprobes onto silicon wafers. (B) the internalisation of the nanoprobes within NIH-3T3 cells was triggered by low-intensity 1 MHz US; the exposure setup employed consists of a water filled tank, a transducer positioned at its bottom and a micro-volume cell holder vertically aligned with the transducer; the sonication was performed on a PBS dispersion of ~106 cells. (C) The samples for SR-microFTIR measurements were prepared by separating the cells from the supernatant and depositing them on silicon substrates by physisorption.
Figure 2SR-microFTIR spectra of bulk 4ATP (purple line) and of 20 nm 4ATP-AuNPs (grey line) acquired at the Diamond Light Source. The estimated enhancement factor due to the SEIRA effect is of ~200.
Figure 3(A) SR-microFTIR spectra of non-treated cells (red curve) compared with those of cells treated with 20 nm 4ATP-AuNPs for 15 minutes, which have internalised a different number of nanoprobes by SP, hence showing different modifications of the spectral profile. (B) SR-microFTIR representative spectrum of a NIH-3T3 cell irradiated with US (16 mW/cm2, 15 minutes) in presence of the 20 nm 4ATP-AuNPs nanoprobe (black line), compared to the SEIRA spectrum of the nanoprobe alone (dashed grey line) is reported; its characteristic peaks at 1400 cm−1 and 1586 cm−1 can be identified in the spectrum of the treated cell, pointing out the internalisation of the nanoprobe.
Figure 4(A) Amide region of the SR-microFTIR spectra of the samples treated with both US and 4ATP-AuNPs for 15 (red line) and 30 minutes (orange line) in comparison with the non-treated control sample (black line); the spectra are normalised to the absorbance of the Amide I band. (B) Representative spectral deconvolution by Gaussian fitting procedure; the spectral components associated to the protein secondary structure are highlighted by filled colour areas (the other spectral components are represented in green). (C) Histograms representing the weight of α-helices (top) and β-sheets (bottom) spectral components in the Amide I band for each sample analysed; each weight was determined as the percent area with respect to the total area of the band. The β-sheets percentage accounts for both the β-structure contributions (1624 cm−1 and 1678 cm-1). Columns and bars represent the average and standard deviation values obtained on at least three independent experiments. *p < 0.05, **p < 0.01 and ***p < 0.001.
Peak assignment of the spectral components resulting from the Amide I band Gaussian deconvolution, according to refs[60,72].
| Peak centre (cm−1) | Assignment |
|---|---|
| 1624 | β-sheets |
| 1639 | random coils |
| 1658 | α-helices |
| 1678 | β-sheets and β-turns |
Figure 5Cell viability determined upon the different treatments by flow cytometry Annexin V and PI combined assay as the percent number of viable cells with respect to the total population of samples analysed. Viability of non-treated control samples (black column) is the same repeated three times. Columns and bars represent the average and standard deviation values obtained on at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.
Figure 6Average number of micronucleated cells (error bars represent the standard deviation), determined upon the different treatments by the CBMN assay. The values are obtained analysing a population of 500 cells for each sample. ***p < 0.001.